Back to search
Transplant Recipient (Kidney)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Transplant Recipient (Kidney) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Transplant Recipient (Kidney) trials you may qualify forAfter a kidney or a simultaneous kidney-pancreas transplant, some patients may face problems with their new organs. This happens because the body sometimes make…
Chronic Allograft Nephropathy (CAN)/Interstitial fibrosis and Tubular Atrophy (IFTA) is responsible for most kidney transplant failures. CAN/IFTA on a 3 month k…
This phase II trial tests the combination of nivolumab and ipilimumab with sirolimus and prednisone for the treatment of skin (cutaneous) cancer that cannot be…
The study aims to determine the short-term efficacy, mechanisms and safety of 12 weeks of dapagliflozin and semaglutide combination therapy in 20 KTR, with and…
The only curative treatment for end-stage renal disease is through kidney transplantation. Solid organ transplants success had been made possible by the develop…
The purpose of this open-label, randomized, active-comparator-controlled study is to determine the efficacy and safety of frexalimab subcutaneous administration…
The purpose of this study is to find out whether letermovir can help prevent cytomegalovirus (CMV) infection in kidney transplant recipients who are CMV seropos…
The goal of this clinical trial is to learn if AIC263029 is safe and well tolerated in adult kidney transplant recipients with BK virus (BKV) in the blood (vire…